Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Concretely: Nestl is pushing Boost and Orgain for GLP-1 users: high protein, easy digestion, added micronutrients Danone is doubling down on high-protein yogurts and medical nutrition, including partnerships with obesity clinics Coca-Cola gets over half its portfolio growth from zero-sugar lines - Coke Zero, flavored waters, low-cal sports drinks General Mills positions high-fiber and high-protein products around satiety and metabolic health Investors are repricing the confectionery and snack sectors
The TrimRx Approach to Personalized Care We understand that weight loss is not a one-size-fits-all journey, especially when you have a history of abdominal surgery
That is especially important for people in Miami Shores, El Portal, Biscayne Park, and nearby areas who are juggling work, commuting, family responsibilities, and inconsistent schedules
However, as part of a comprehensive treatment plan, these medications offer a unique ability to lower inflammation, reduce metabolic burden, and improve quality of life
Heres what it means for Medicaid enrollees: Medicaid access through the BALANCE Model could begin as early as May 2026 States must opt in voluntarily its not automatic Participating states receive federally negotiated prices from Eli Lilly (Zepbound, Mounjaro) and Novo Nordisk (Wegovy, Ozempic) Wegovy and Zepbound starting doses would cost the program $350/month (reduced from over $1,000) Patients in participating states would pay $50/month for covered GLP-1s Prior authorization and qualifying criteria will still apply This is the biggest potential expansion of GLP-1 access for Medicaid enrollees in history but it depends on your state deciding to participate
US$ 26.63
US$ 23.16
US$ 27.75
US$ 29.26
US$ 21.74
US$ 23.28
US$ 29.34
US$ 20.45
US$ 27.89
